Policy

Latest News

laboratory for biosimilars | Image credit: Shutter2U - stock.adobe.com
BioRationality: Questioning Experts and Journals Reporting on Biosimilar Bill to Remove Interchangeability

June 23rd 2025

The debate over the Biosimilar Red Tape Elimination Act raises critical concerns about FDA standards, physician trust, and patient safety in biosimilars.

child in need of psoraisis biosimilar | Image credit: WESTOCK - stock.adobe.com
FDA Approves Steqeyma for Children With Plaque Psoriasis, Psoriatic Arthritis

June 17th 2025

doctor talking about biosimilar adalimumab with patient | Image credit: Prostock-studio - stock.adobe.com
New Data Support Hulio as an Interchangeable Adalimumab Option

June 16th 2025

vials | Image credit: pixardi - stock.adobe.com
BioRationality: The Urgency of Removing Clinical Efficacy Studies

June 2nd 2025

Eye on Pharma banner
Eye on Pharma: Interchangeability Labels and Expanded Biosimilar Partnerships

May 29th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.